Furanopyridine derivatives as ACK1 and Lck modulators

Details for Australian Patent Application No. 2005332339 (hide)

Owner Amgen Inc.

Inventors Jiao, Xianyun; Fu, Jiasheng; Nunes, Joseph J.; Martin, Matthew W.; White, Ryan; Liu, Jinqian; Kayser, Frank; Bemis, Jean E.; McGowan, David

Agent Wrays

Pub. Number AU-B-2005332339

PCT Pub. Number WO2006/130160

Priority 60/590,472 23.07.04 US; 11/184,237 18.07.05 US

Filing date 19 July 2005

Wipo publication date 7 December 2006

Acceptance publication date 24 September 2009

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/130160 Priority application(s): WO2006/130160

24 September 2009 Application Accepted

  Published as AU-B-2005332339

21 January 2010 Standard Patent Sealed

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005332342-A method for improving flux in a membrane bioreactor

2005332334-Information security for aeronautical surveillance systems